Division Faculty & Instructors

Dr. Justin Annes, MD, PhD, specializes in the treatment of hereditary endocrine disorders with particular focus on neuroendocrine-related conditions. He developed the Stanford Endocrine Genetics Clinic in 2012 which is part of the interdisciplinary Stanford Hypertension Center and Stanford Neuroendocrine Tumor Program. 
He has medical practice has focused on hereditary endocrine disease since 2008.

Dr. Danit Ariel, MD, MS, is a board-certified endocrinologist.  Dr. Ariel graduated from UC Davis School of Medicine, completed residency in Internal Medicine at Stanford, followed by a fellowship and post-doctorate in Endocrinology and Metabolism at Stanford before joining the faculty. She is also a NAMS Certified Menopause Practitioner. Dr. Ariel’s clinical and academic practice focuses on gender-related hormones: including providing gender affirming hormone care, treatment of peri-menopausal and menopausal symptoms, male hypogonadism, pregnancy related thyroid disease, and amenorrhea. She also specializes in thyroid disorders. In addition, she is actively involved in the Stanford School of Medicine coaching medical students in her role as the Founding Director of the Student Guidance Program. Finally, she serves as the Director of Faculty Well-being for the Division of Endocrinology. Through all of her endeavors, she strives to bring compassion, respect, and inclusivity towards others.

Dr. Marina Basina, MD, is a clinical endocrinologist and clinical researcher with a focus on diabetes management, thyroid, and adrenal conditions. Her primary interests are in Type 1 Diabetes, Diabetes technology, and Diabetes in pregnancy. Dr Basina is Board certified in Endocrinology and Internal Medicine. She received numerous teaching awards and Stanford Hospital award for excellence in patient care. She is an active member of medical advisory boards for several community diabetes organizations. Dr Basina is a medical director of inpatient diabetes program at Stanford and a chair of diabetes task force.

To view active studies - click here

Dr. Julia Chang, MD, is a clinical assistant professor in endocrinology at Stanford University. She completed her MD at Case Western Reserve University and her residency and fellowship training at Stanford. Dr. Chang practices general endocrinology with a special interest in gender-affirming hormone care and pituitary disorders.

Dr. Julie Chen, MD, is a clinical assistant professor in endocrinology at Stanford University.  Dr. Chen practices general endocrinology but her clinical interest include thyroid disease/thyroid cancer, pituitary disease, and disorders of the bone. She also has a special interest in medical education and developed online teaching resources for the endocrine fellowship program.

Dr. Katrin Chua, MD, directs a research program focused on fundamental mechanisms of chromatin regulation and genome maintenance and how they impact onaging, cancer and other age-related disease processes. For over 15 years, her laboratory has pioneered studies of the mammalian SIRT6 and SIRT7 genes and elucidated their roles as master regulators of cellular aging, metabolism, stress resistance, and longevity. In addition to training students and post-doctoral fellows in her lab, Dr. Chua serves as Director of the Stanford MD-PhD Medical Scientist Training Program, and is dedicated to ensuring that the Stanford MSTP continues to be an international leader in training a diverse group of future physician-scientists who will have a lasting impact on medicine and biomedical research.

Dr. Dimpi Desai, MD is a Clinical Assistant Professor at Stanford University and is dual board certified in Internal Medicine and Endocrinology. She completed her fellowship in Endocrinology at the University of Pennsylvania. Her main clinical focus includes diabetes and obesity and preventing their long-term complications. She also has an interest in both benign and malignant thyroid disorders. She strongly believes in patient education and involving them in the medical decision-making process. In addition to being a clinician, she is committed to the medical education of residents and fellows.

Dr. Kaniksha Desai, MD,  is a board-certified endocrinologist and clinical associate professor of endocrinology at Stanford University. She completed her endocrinology fellowship at the Mayo Clinic, with an emphasis on the management of patients with thyroid cancer. Dr. Desai’s clinical practice focuses on the management of patients with thyroid diseases, including thyroid nodules and thyroid cancers, and the management of patients with pituitary disorders. She also maintains board certification in neck ultrasonography and internal medicine.

Dr. Chrysoula Dosiou, MD, MS, specializes in the treatment of patients with thyroid disease. She has a special interest in the evaluation and treatment of thyroid disease in the setting of pregnancy and the care of patients with thyroid-eye disease.

Dr. Neil Gesundheit, MD, MPH, is a board-certified endocrinologist who trained in the clinical thyroid unit at the National Institutes of Health. He sees hospitalized general endocrine patients at Stanford and the Palo Alto Veterans Administration Hospitals. He directs the second-year medical student endocrine physiology course and is deeply involved in education and in overseeing the career development of Stanford medical students, residents, and fellows.

Dr. Andrew Hoffman, MD, is a board certified endocrinologist who specializes in the treatment pituitary and other neuroendocrine diseases, including acromegaly, Cushing syndrome, prolactinomas and other pituitary tumors. His current laboratory research is examining the role of epigenetics, including long noncoding RNAs, DNA methylation, histone changes and long range chromatin interactions, in normal biology and in cancer.

Dr Michael Hughes, MD is an instructor in the endocrinology department at Stanford University. He has clinical and research interests in type 1 diabetes, diabetes technology (particularly use in the hospital), and transitions of care from pediatric to adult medicine. His research is supported by an NIH-funded K12 grant, “Training Research Leaders in Type 1 Diabetes.”

Dr. Laurence Katznelson, MD, received his medical degree from the University of California, Los Angeles and performed his internship and residency in Internal Medicine at the Hospital of the University of Pennsylvania, Philadelphia. He then performed a fellowship in Endocrinology and Metabolism at the Massachusetts General Hospital, Boston. Dr. Katznelson is a Professor of Neurosurgery and Medicine at Stanford University School of Medicine,and Associate Dean, Graduate Medical Education. His clinical interests are pituitary disorders, including acromegaly, Cushing disease, prolactinoma, and hypopituitarism

Dr. Seung Kim, MD, PhD, is a researcher and his lab studies pancreas developmental biology and cancer biology in several models, including fruit flies, mice and humans. His lab has innovated methods for studying pancreas biology in these models, and discovered cellular, molecular and genetic mechanisms governing islet β-cell growth, development and function in mouse and human pancreas. One goal of the lab’s research is to translate studies into novel diagnostic and therapeutic strategies for common pancreatic disease states in humans, particularly diabetes mellitus and pancreatic cancer. Dr. Kim has also contributed to science education in multiple ways over the past two decades as a PI and mentor in several graduate and post-graduate training programs at Stanford and a high school program in New England, and is committed to training the next generation of biomedical researchers.

Dr. Sun Kim, MD, MS, is a board-certified endocrinologist who specializes in the treatment of type 2 diabetes, polycystic ovarian syndrome (PCOS), and obesity. She is particularly devoted to helping individuals change their lifestyles and achieve sustained improvements in their health.  Dr. Kim also conducts translational research in insulin resistance and type 2 diabetes. She is the co-leader of the Stanford Diabetes Research Center Metabolism and Signaling Affinity Group

Dr. Fredric Kraemer, MD, research is directed at understanding cellular lipid metabolism, with a focus on the regulation of fatty acid flux in adipose cells and on cholesterol trafficking for steroid hormone production.

Dr. Rayhan Lal, MD, is pediatric and adult endocrine faculty at Stanford. He grew up in the California bay area and always wanted to be an engineer. Rayhan has had type 1 diabetes for 30 years. He studied electrical engineering and computer science at U.C. Berkeley. His two younger sisters were enrolled in DPT-1, found to have autoantibodies and developed type 1 diabetes.  Rayhan switched career paths and attended medical school at U.C. Davis. He completed residency in medicine and pediatrics at USC, working with the underserved at LA County Hospital. Rayhan then completed adult and pediatric endocrine fellowships at Stanford.  As an engineer and physician-scientist with diabetes, his research interest is the design, development and testing of new diabetes technology with his mentor, Dr. Buckingham. Rayhan collaborates with members of the Stanford Diabetes Research Center, industry and open-source diabetes community to bypass the biological, technological and human factor limitations of existing devices.

Dr. Jennifer Lee, MD, PhD, is an endocrinologist and clinical investigator (PhD Epidemiology, Stanford). Her group focuses on pattern mapping along the life-course risk factors and outcomes and how healthcare system can positively impact health longitudinally. Her group aims to use novel molecular epi, 'big' data, & new designs/methods/tech of clinical trials and observational designs, for better insights to etiology & enhanced health services & delivery. These interests cut across multiple complex chronic diseases, aging, & critical lifespan stages.

Dr Jenny Sooyeon Lee, PhD is an instructor in the endocrinology department at Stanford University. Her research interests are in diabetes, cellular aging, and mitochondrial metabolism. Currently, she focuses on understanding how the age-dependent evolution of β-cell metabolic behavior leads to diabetes development.

Dr. Elizabeth McAninch, MD, is a clinical associate professor in endocrinology at the Stanford University School of Medicine. She has a BA in Mathematics from Smith College and earned her MD at the University of Miami Miller School of Medicine. She then completed her internal medicine residency and endocrinology fellowship at the University of Miami. She has dual board certification in internal medicine and endocrinology. At Stanford, her clinical practice focuses on functional and structural thyroidology, as well as other endocrine neoplasia (benign or malignant tumors within the endocrine glands). She collaborates within our internationally-recognized, multidisciplinary Endocrine Neoplasia Program to help patients navigate these complex diagnoses.

Dr. Tracey McLaughlin, MD, is a clinician investigator who maintains an active clinic for patients with complicated type 1, type 2, or other forms of diabetes, polycystic ovarian disease, and hypoglycemia. Her clinical research program includes human studies on obesity, regional fat distribution, and the role of adipocytes and adipose tissue immune cells in promoting insulin resistance and type 2 diabetes. She also conducts studies on the role of incretin hormones in glucose metabolism and postbariatric hypoglycemia, and the use of continuous glucose monitoring and multi-omics methods to define metabolic sub-phenotypes and precision diets for individuals with prediabetes and type 2 diabetes.

Active Studies on Dr. McLaughlin's Research page and the Endocrinology Clinical Trials page.

Dr. Yasaman Motlaghzadeh, MD, MPH, is a clinical assistant professor in endocrinology at Stanford University School of Medicine. She completed her MD, MPH at Tehran University of Medical Sciences and Internal Medicine residency at Rutgers New Jersey Medical School. She then performed fellowship training at Stanford University. Dr. Motlaghzadeh’s clinical practice focuses on the management of patients with Metabolic Bone Disease. 

Dr. Deborah Sellmeyer, MD, is an internationally recognized expert in Metabolic Bone Disease. She is a renowned clinician who joined the Stanford faculty in 2018 as a Professor of Medicine. She has been recognized for her clinical excellence with induction into the Miller Coulson Academy of Clinical Excellence while she was at Johns Hopkins. In addition to her clinical expertise, Dr. Sellmeyer maintains a research program that centers on the effect of nutrition and environmental factors on skeletal metabolism which she has investigated through both smaller CRC-based trials and large multi-center trials.

Dr. Aimee Shu, MD, is an endocrinologist with particular interests in reproductive and bone health. 

I enjoy treating patients with menstrual disorders, menopause, fractures, osteoporosis, parathyroid imbalance, and calcium imbalance. 

Dr. Marilyn Tan, MD, is double board certified in Endocrinology and Internal Medicine. She practices general endocrinology, but her main clinical interests are outpatient and inpatient diabetes management. Her research interests include diabetes and post bariatric hypoglycemia. Dr. Tan is actively involved in resident and fellow education, and she has served as the Medical Student Clerkship Director, Residency Rotation Director, and Associate Program Director for the Endocrinology Fellowship Training Program. She is the chief of the Stanford Endocrine Clinic.

Dr. Molly Tanenbaum, PhD, is a licensed clinical psychologist and a clinical researcher whose work focuses on two main areas: understanding and optimizing the role of technology (e.g. continuous glucose monitoring, closed-loop systems) to improve diabetes management; and understanding and attending to the emotional experience of living with diabetes. Dr. Tanenbaum also has an interest in the role of self-compassion in diabetes. Clinically, Dr. Tanenbaum provides consultation and behavioral medicine interventions with people living with diabetes.

Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD) Trial

Dr. Joy Wu, MD, PhD, is a board-certified endocrinologist with over 12 years' experience who specializes in treating women and men with osteoporosis and other bone and mineral diseases, including primary hyperparathyroidism, vitamin D deficiency, Paget's disease and fibrous dysplasia. She has a special interest in optimizing skeletal health for those at risk of bone loss from glucocorticoid treatment, cancer therapies, or organ transplant. She works closely with each individual and his/her referring physician to assess fracture risk, and to develop a tailored treatment and monitoring plan.